Prelude Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-10,550
| Closed | -$1.08M | – | 1349 |
|
|
2023
Q2 | $1.08M | Buy |
+10,550
| New | +$1.08M | 0.07% | 260 |
|
|
2021
Q2 | – | Sell |
-10,050
| Closed | -$1M | – | 1736 |
|
|
2021
Q1 | $1M | Buy |
+10,050
| New | +$1M | 0.03% | 364 |
|
|
2020
Q4 | – | Sell |
-7,652
| Closed | -$745K | – | 1719 |
|
|
2020
Q3 | $745K | Buy |
7,652
+7,267
| +1,888% | +$708K | 0.04% | 206 |
|
|
2020
Q2 | $60K | Buy |
+385
| New | +$60K | ﹤0.01% | 778 |
|
|
2020
Q1 | – | Sell |
-19,423
| Closed | -$3.97M | – | 1706 |
|
|
2019
Q4 | $3.97M | Sell |
19,423
-34,453
| -64% | -$7.04M | 0.15% | 30 |
|
|
2019
Q3 | $4.33M | Buy |
53,876
+11,182
| +26% | +$898K | 0.19% | 30 |
|
|
2019
Q2 | $4.03M | Buy |
+42,694
| New | +$4.03M | 0.2% | 44 |
|
|
2018
Q2 | – | Sell |
-12,412
| Closed | -$255K | – | 1743 |
|
|
2018
Q1 | $255K | Buy |
+12,412
| New | +$255K | 0.02% | 553 |
|